CARTISTEM vs surgery for knee cartilage damage and osteoarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests if a cell-based treatment called CARTISTEM can repair knee cartilage better than surgery alone. It involves people with knee osteoarthritis and a cartilage defect, with moderate pain and limited function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 75.
- Diagnosed with knee osteoarthritis and have a cartilage defect in the knee (at least 2 cm²).
- Moderate to severe pain and difficulty with daily activities.
- Able to stop using pain medicines for 2 days before visits.
- Stable health, with no major uncontrolled diseases.
- Willing to follow strict rehab and avoid other knee treatments during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new stem cell treatment, given during a surgical procedure, can help repair damaged cartilage in the knee. It is for people with moderate to severe knee pain and a specific size of cartilage injury.
This Phase 2 study tests CartiLife® to help repair a specific type of damaged knee cartilage. You may be considered if you have a moderate-sized cartilage defect in the knee and enough pain and function limits to need treatment.
This trial tests a new treatment that uses your own bone marrow cells to grow a piece of tissue to repair damaged knee cartilage. It's for people with a single, medium-sized cartilage injury on the thigh bone part of the knee joint that hasn't gotten better with other treatments.
This study looks at knee osteoarthritis to find new ways to treat it. If you have knee pain from worn-down cartilage, this research may lead to better therapies.
This study compares two surgical techniques to repair large cartilage or bone defects in the knee, which can cause pain and limit movement. If you have a significant knee injury that hasn't improved with other treatments, you may be able to join and help find which method works best.
This trial tests a new cell-based treatment (CLS2901C) for knee osteoarthritis. It combines the treatment with a realignment surgery (proximal tibial osteotomy) to help repair cartilage damage and reduce pain.
Hear when a new Knee Cartilage Defects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.